Literature DB >> 23769573

Recipient dendritic cells modified by RNA interference targeting CD80 and CD86 elicit T cell hyporesponsiveness via enhanced T cell apoptosis.

Jun Hong1, Xiao-dong Gu, Jian-bin Xiang, Zhe Zhang, Yi-wen Zang, Qun-hua Zhang, Shi-guang Qian, Zong-you Chen.   

Abstract

BACKGROUND: Despite extensive research, the mechanism of immature dendritic cells (DCs) induced immune hyporesponsiveness remains incompletely understood.
METHODS: Recipient DCs from C3H mouse bone marrow cells were incubated with donor antigen from splenic lymphocytes of C57BL/6 mouse; these DCs were transfected with CD80/86 specific siRNA using lentiviral vectors. Flow cytometry was used to evaluate expression of CD80/86 on the antigen-pulsed recipient DCs. Immune regulatory activity was examined by mixed lymphocyte reaction, in which irradiated DCs were cultured with C3H spleen T cells. After the reaction, interleukin (IL)-2, IL-4, IL-10, and interferon (INF)-γ levels of mixed lymphocyte reaction culture supernatant were measured by enzyme-linked immunosorbent assay. The apoptotic T lymphocytes were identified by Annexin V and CD3 staining.
RESULTS: There was a significant inhibition of CD80/86 expression in DCs transfected with CD80/86 lentiviral vectors compared with the control groups (P < 0.05), indicating the specificity of RNA interference. Enzyme-linked immunosorbent assay results showed a significant reduction of INF-γ, IL-2 and IL-10 in the CD80/86 lentivirus transfected group compared to the control groups (P < 0.05). There was no significant difference in IL-4 levels between the groups (P > 0.05). We also showed that CD80/86 low DCs loaded with alloantigen (1) stimulated low T cell proliferative responses via the indirect recognition pathway and (2) enhanced apoptotic activity (P < 0.05) in co-cultured T cells.
CONCLUSIONS: Lentiviral vector transfection can effectively and specifically knock down target genes in DCs. The CD80/86 low DCs may show tolerogenic activity via induction of T-cell apoptosis, thereby modulating the activity of recipient-derived DCs. The use of this approach may potentially be clinically applicable.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23769573

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  3 in total

1.  Emodin induces apoptosis of concanavalin A-stimulated murine splenocytes.

Authors:  Subin An; So Jin Bing; Jinhee Cho; Kalahe Hewage Iresha Nadeeka Madushani Herath; Areum Kim; Hyeun Wook Chang; Youngheun Jee
Journal:  Food Sci Biotechnol       Date:  2016-12-31       Impact factor: 2.391

Review 2.  Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy.

Authors:  Thiago A Patente; Mariana P Pinho; Aline A Oliveira; Gabriela C M Evangelista; Patrícia C Bergami-Santos; José A M Barbuto
Journal:  Front Immunol       Date:  2019-01-21       Impact factor: 7.561

3.  Enhanced immunogenicity of leukemia-derived exosomes via transfection with lentiviral vectors encoding costimulatory molecules.

Authors:  Weiwei Hu; Fang Huang; Liuxin Ning; Jun Hao; Jiangbo Wan; Siguo Hao
Journal:  Cell Oncol (Dordr)       Date:  2020-06-23       Impact factor: 6.730

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.